Checkpoint Therapeutics, Inc.
CKPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,240 | -$51,847 | -$62,624 | -$56,670 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $15,252 | $2,897 | $2,924 | $3,137 |
| Change in WC | $1,181 | -$2,794 | -$4,608 | $19,596 |
| Other Non-Cash | $8,706 | $4,154 | $6,754 | $7,631 |
| Operating Cash Flow | -$31,101 | -$47,590 | -$57,554 | -$26,306 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $26,000 | $33,621 | $17,620 | $41,279 |
| Stock Repurch. | $0 | $0 | -$6 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,777 | $6,829 | -$2,727 | -$1,010 |
| Financing Cash Flow | $32,777 | $40,450 | $14,887 | $40,269 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,676 | -$7,140 | -$42,667 | $13,963 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,928 | $12,068 | $54,735 | $40,772 |
| End Cash | $6,604 | $4,928 | $12,068 | $54,735 |
| Free Cash Flow | -$31,101 | -$47,590 | -$57,554 | -$26,306 |